August 23, 2024Anesthesia & Analgesia

Sugammadex Versus Neostigmine for Bariatric Surgery: Methodological Concerns

View Full Paper

Ask AI

Bookmark

Authors

YMYusuke MiyazakiJikei University School of Medicine KSKaoru SuzukiJikei University School of Medicine KYKentaro YamakawaTokyo Institute of Technology

Discussion

Member takes

Implication

Methodological commentary addresses comparative evaluations of sugammadex versus neostigmine in bariatric surgery, highlighting the need for rigorous study designs.

Key Points

Methodological concerns surround the comparative outcomes of sugammadex and neostigmine, questioning the validity of reported recovery metrics during bariatric surgery procedures.
Critical commentary evaluates observational and clinical comparisons between sugammadex and neostigmine, emphasizing potential confounding factors within bariatric surgery cohorts.
Rigorous methodological standards are required when assessing sugammadex versus neostigmine, guiding improved perioperative drug selection for patients undergoing bariatric surgery.

Cite This Study

Miyazaki et al. (2024) studied this question.

synapsesocial.com/papers/68e5b3bab6db64358754cd4e https://doi.org/10.1213/ane.0000000000007194

View Full Paper

Ask AI

Bookmark

Implication

Methodological commentary addresses comparative evaluations of sugammadex versus neostigmine in bariatric surgery, highlighting the need for rigorous study designs.

Sugammadex Versus Neostigmine for Bariatric Surgery: Methodological Concerns

Discussion

Member takes

Implication

Key Points

Cite This Study

Sugammadex Versus Neostigmine for Bariatric Surgery: Methodological Concerns

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider